A patient should not have to guess whether a symptom is normal, whether a dose is too high, or whether treatment should be paused
New pricing for new accounts only effective as of July 27, 2026
This month, the Centers for Medicare and Medicaid Services launched the Medicare GLP-1 Bridge, a demonstration program that gives eligible Medicare beneficiaries access to certain anti-obesity medicines for $50 a month
Still, clinical trials are already exploring what doses work best for weight loss with the fewest side effects and how different doses are introduced and increased over time, which gives us helpful clues about how it may eventually be taken
Revista da Faculdade de Cincias Mdicas de Sorocaba , Sorocaba, v
GLP-1 for food cravings: They reduce food-related thoughts and the dopamine-driven desire to overeat